| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 03/05/2008 | EP1893559A2 Process for preparation of sertraline hydrochloride form i |
| 03/05/2008 | EP1893226A1 Cyclosporins to treat alzheimer's disease |
| 03/05/2008 | EP1893212A2 Multicyclic compounds and methods of their use |
| 03/05/2008 | EP1893202A2 Multimediator dopamine transport inhibitors, and uses related thereto |
| 03/05/2008 | EP1893200A2 Carbamate derivatives as positive allosteric modulators of metabotropic glutamate receptors |
| 03/05/2008 | EP1893191A1 Medicinal acidic cannabinoids |
| 03/05/2008 | EP1893188A1 Compounds useful for treating bipolar disorders |
| 03/05/2008 | EP1893185A2 Use of urokinase inhibitors for the treatment and/or prevention of neuropathological diseases |
| 03/05/2008 | EP1758600A4 Methods and compositions for treating mood disorder |
| 03/05/2008 | EP1732541A4 Cyclic compounds |
| 03/05/2008 | EP1713797B1 1-isopropyl-2-oxo-1,2-dihydropyridine-3-carboxamide derivatives having 5-ht4 receptor agonistic activity |
| 03/05/2008 | EP1697362B1 Crf receptor antagonists and methods relating thereto |
| 03/05/2008 | EP1644351B1 Imidazole derivatives and their use in the treatment of mGluR5 receptor mediated disorders |
| 03/05/2008 | EP1383733B1 Process for the preparation of 1,3-substituted indenes and aryl-fused azapolycyclic compounds |
| 03/05/2008 | EP1368253B1 Inhaler with means for improving chemical stability of medicinal aerosol solution contained therein |
| 03/05/2008 | EP1368020B1 Method for identifying maxi-k channel blockers |
| 03/05/2008 | EP0989993B1 Tartrate salt of a substituted dipeptide as growth hormone secretagogue |
| 03/05/2008 | CN101137755A Method for gene delivery to neuronal cells |
| 03/05/2008 | CN101137658A Antipruritic agent for pruritus caused by multiple sclerosis |
| 03/05/2008 | CN101137657A Diaza-spiro-[4.4]-nonane derivatives as neurokinin (NK1) antagonists |
| 03/05/2008 | CN101137653A Thiazole-4-carboxamide derivatives as MGLUR5 antagonists |
| 03/05/2008 | CN101137648A Crystalline and amorphous 4-cyano-n-{(2r)-2-[4-(2,3-dihydro-benzo[1,4]dioxin-5-yl)-piperazin -1-yl]-propyl}-n-pyridin-2-yl-benzamide hydrochloride |
| 03/05/2008 | CN101137645A Aryl piperazine derivatives for the treatment of neuropsychiatric disorders |
| 03/05/2008 | CN101137638A Substituted aminoalkyl- and amidoalkyl-benzopyran derivatives |
| 03/05/2008 | CN101137630A Non-anilinic derivatives of isothiazol-3(2h)-thione 1,1-dioxides as liver x receptor modulators |
| 03/05/2008 | CN101137629A Non-anilinic derivatives of isothiazol-3(2h)-thione 1,1-dioxides as liver x receptor modulators |
| 03/05/2008 | CN101137628A Non-anilinic derivatives of isothiazol-3(2h)-one 1,1-dioxides as liver x receptor modulators |
| 03/05/2008 | CN101137625A Cinnamate salts of a beta-2 adrenergic agonist |
| 03/05/2008 | CN101137397A Amyloid imaging as a surrogate marker for efficacy of anti-amyloid therapies |
| 03/05/2008 | CN101137389A Pulsatilla spp. extracts effective in brain function |
| 03/05/2008 | CN101137366A Compounds for treating autoimmune and demyelinating diseases |
| 03/05/2008 | CN101137363A [4-(heteroaryl)piperazin-1-yl]-(2,5-substituted -phenyl)methanone derivatives as glycine transporter 1 (Glyt-1) inhibitors for the treatment of neurological and neuropsychiatric disorders |
| 03/05/2008 | CN101134780A Polypeptide analogue for blocking NR2B signal path and preparation method and medical usage thereof |
| 03/05/2008 | CN101134775A Novel streptococcus antigens |
| 03/05/2008 | CN101134774A Combined chemical modified endomorphin-1 and method for preparing same |
| 03/05/2008 | CN101134757A 稠合杂环化合物 Fused heterocyclic compounds |
| 03/05/2008 | CN101134093A Pills for treating psychosis and method for processing the same |
| 03/05/2008 | CN101134085A Traditional Chinese medicine for treating apoplexy and hemiplegia |
| 03/05/2008 | CN101134076A Traditional Chinese medicine for treating apoplectic aphasia |
| 03/05/2008 | CN101134075A Quick-effective drunkenness dispelling liquid |
| 03/05/2008 | CN101134069A Capsule for treating hieronosus |
| 03/05/2008 | CN101134062A Specific analgesic liniment |
| 03/05/2008 | CN101134061A Traditional Chinese medicine for treating chronic headache |
| 03/05/2008 | CN101134048A Medicament for preventing and treating alzheimer's disease and caducity |
| 03/05/2008 | CN101134041A Antidepressant and uses thereof |
| 03/05/2008 | CN101134037A Rimonabant or the enteric-coated preparations of the rimonabant medical salts and method for preparing the same |
| 03/05/2008 | CN101133827A Application of ackfruit extract in the aspect of relieving or neutralizing the effect of alcohol |
| 03/05/2008 | CN101133792A Wilding synthesized naked oat legume oat compressed granules and orange juice and method of processing the same |
| 03/05/2008 | CN101133791A Wilding synthesized corn, peanut, lotus seed compressed granules and orange juice beverage and method for processing the same |
| 03/05/2008 | CN100372865C Saponin compound and use of its glucoside in preparing medicine for treating neure injure |
| 03/05/2008 | CN100372860C I*-salidroside and its preparation and use in anti-senile dimentia medicine |
| 03/05/2008 | CN100372851C Fused pyrimidine derivatives with CRF activity |
| 03/05/2008 | CN100372849C Pyrrolo pyrimidine compounds as inhibitor of cysteine protease |
| 03/05/2008 | CN100372848C Spiroazacyclic compounds as monoamine receptor modulators |
| 03/05/2008 | CN100372846C Sulfonamido substituted imidazopyridines |
| 03/05/2008 | CN100372845C Polycyclic compounds as potent alpha2-adrenoceptor antagonists |
| 03/05/2008 | CN100372844C 2-imidazo-benzothiazoles as adenosine receptor ligands |
| 03/05/2008 | CN100372838C Piperidine-benzenesulfonamide derivatives |
| 03/05/2008 | CN100372564C Medicine for preventing and treating brain traumatic reaction syndrome |
| 03/05/2008 | CN100372553C Tranquilizing and blood nourishing oral liquid |
| 03/05/2008 | CN100372533C Therapeutic formulation for mainly of diarrhea large intesitine irritation syndrome |
| 03/05/2008 | CN100372528C Ginkgolide B soft capsule and its preparing method |
| 03/04/2008 | US7338974 Macrocyclic diaminopropanes as beta-secretase inhibitors |
| 03/04/2008 | US7338970 Containing microcrystalline cellulose, lubricant, colloidal silica and lactose; use in treating depression, Parkinson's disease and severe psychotic disorders, such as schizophrenia and schizoaffective disorders. |
| 03/04/2008 | US7338966 Substituted oxindole derivatives as tyrosine kinase inhibitors |
| 03/04/2008 | US7338965 Enzyme inhibitors of beta-secretase which cleaves amyloid precursor protein present in Alzheimer's disease; Trisomy 21 (Down's Syndrome); Hereditary Cerebral Hemorrhage; cognition activators; Parkinson's disease |
| 03/04/2008 | US7338960 {[2-Methyl-4-({[4'-(trifluoromethyl)-3-biphenylyl]methyl}thio)phenyl]oxy}acetic acid; adipogenic signalling cascade and lipid homeostasis; increase High Density Lipoproteins; hypotensive agent; Syndrome X, obesity, insulin resistance, cardiovascular disorder |
| 03/04/2008 | US7338955 Medicament for treatment of neuropathies |
| 03/04/2008 | US7338953 Administering racemic reboxetine or a salt thereof for inhibition of norepinephrine reuptake |
| 03/04/2008 | US7338948 Use of quetiapine |
| 03/04/2008 | US7338929 Cancer immunotherapy |
| 03/04/2008 | US7338772 RF-amide peptides and their use for treating, preventing and curing neurological and metabolic medical disorders. The invention also relates to methods for modulating a G-protein coupled receptor and for identifying substances which modulate |
| 03/04/2008 | US7338666 Methods for modulating the axonal outgrowth of central nervous system neurons |
| 02/28/2008 | WO2008024979A2 Methods utilizing cell-signaling lysophospholipids |
| 02/28/2008 | WO2008024945A1 Indazole derivatives that inhibit trpv1 and uses thereof |
| 02/28/2008 | WO2008024930A2 Intrathecal administration of triptan compositions to treat non-migraine pain |
| 02/28/2008 | WO2008024893A2 Derivatives of uric and thiouric acid for oxidative stress-related diseases |
| 02/28/2008 | WO2008024776A1 Inhibiting jnk signaling promotes cns axon regeneration |
| 02/28/2008 | WO2008024677A1 Biomarkers for alzheimer's disease progression |
| 02/28/2008 | WO2008024492A2 Indolinone phenylaminopropanol derivatives and process for the preparation thereof |
| 02/28/2008 | WO2008024151A2 Salts and co-crystals of pyrazolopyrimidine compounds, compositions thereof and methods for their production and use |
| 02/28/2008 | WO2008024029A1 Substituted azepino[4,3-b]indoles, pharmacological composition and a method for the production and use thereof |
| 02/28/2008 | WO2008023847A1 P2x4 receptor antagonist |
| 02/28/2008 | WO2008023725A1 Preventive and/or therapeutic agent for peripheral neuropathy |
| 02/28/2008 | WO2008023357A1 Heterocyclic derivatives binding to the peripheral-type benzodiazepine receptor (pbr) |
| 02/28/2008 | WO2008023258A1 Piperidine derivatives |
| 02/28/2008 | WO2008022976A1 Synthesis, polymorphs, and pharmaceutical formulation of a faah inhibitor |
| 02/28/2008 | WO2008022396A1 Fluorinated ligands for targeting peripheral benzodiazepine receptors |
| 02/28/2008 | WO2008008821A3 Use of trifluoromethyl substituted benzamides in the treatment of neurological disorders |
| 02/28/2008 | WO2008007123A3 Pharmaceutical compounds |
| 02/28/2008 | WO2008006979A3 Process for preparing diaminophenothiazinium compounds |
| 02/28/2008 | WO2008000744A3 2-0'-methyladen0sine derivatives and their use as agonists or antagonists of an adenosine receptor |
| 02/28/2008 | WO2007149030A8 Novel heteroaryl substituted benzoxazoles |
| 02/28/2008 | WO2007137167A3 Co-therapy for the treatment of epilepsy |
| 02/28/2008 | WO2007112757A3 A process for concentration of a polypeptide |
| 02/28/2008 | WO2007091159A3 Compositions and methods for treating lysosomal storage diseases |
| 02/28/2008 | WO2007090617A3 Thiadiazole derivatives for the treatment of neuro degenerative diseases |
| 02/28/2008 | WO2007045959A3 Antioxidant and fe2+chelating properties of herbal extracts |
| 02/28/2008 | WO2007017510A3 Isophthalic acid diamides for treating alzheimer's disease |
| 02/28/2008 | WO2007016095A3 Cyclooxygenase-2 selective inhibitor compounds comprising nitric oxide enhancing groups, compositions and methods of use |